PA000051-ANT-327: GroEL (HSP60) Monoclonal Antibody
Mouse Monoclonal Antibody;
Applications: ELISA, WB, IHC;
Reactivity: Human;
Clone: P2E4AT;
Isotype: Mouse IgG1.PA005147-ANT-112: IL-10 Monoclonal Antibody
Mouse Monoclonal Antibody;
Applications: WB, IP, IHC, ELISA;
Reactivity: Human;
Clone: NYR-HIL10;
Isotype: Mouse IgG1.PA005147-ANT-113: IL-10 Monoclonal Antibody
Rat Monoclonal Antibody;
Applications: ELISA, WB, IP, IHC, Intracellular staining;
Reactivity: Mouse;
Clone: NYRmIL-10;
Isotype: Rat IgM.BP000133-CYT-404: Recombinant Porcine Interleukin-10 (IL-10) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of MC/9 cell which was found to be < 15 ug/ml corresponding to a Specific Activity of 66,667 IU/mg.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000133-CYT-465: Recombinant Rat Interleukin-10 (IL-10) Protein
Source: E. coli-derived.
The ED50 as determined by the dose dependent inhibition of MC/9 proliferation is less than 10 ug/ml concentration corresponding to a Specific Activity of 100,000 IU/mg.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000133-CYT-486: Recombinant Human Interleukin-10 (IL-10) Protein, His
Source: E. coli-derived.
Purity: > 95% by SDS-PAGE.BP000133-CYT-497: Recombinant Mouse Interleukin-10 (IL-10) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant co-stimulation with IL-4 of mouse MC-9 cells was found to be < 2 ug/ml, corresponding to a Specific Activity of 500,000 IU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000133-CYT-500: Recombinant Human Interleukin-10 (IL-10) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependent co-stimulation (with murine IL-4) of MC/9 cells was found to be less than 2.0 ug/ml, corresponding to a specific activity of 5.0?05 IU/mg.
Purity: > 97% by SDS-PAGE and RP-HPLC.BP000143-CYT-363: Recombinant Human IL-19
Source: E. coli-derived.
The activity is determined by it's ability to activate STAT following receptor-ligand interaction.
Purity > 99%, by SDS-PAGE and RP-HPLC.BP000143-CYT-411: Recombinant Mouse IL-19
Source: E. coli-derived.
The biological activity was determined by measuring the dose-dependent activation of STAT3 in human epidermal keratinocytes (HEK2a cells). Significant STAT3 activation is observed with >100 ug/ml corresponding to a Specific Activity of 10,000 IU/mg of recombinant mouse IL-19.
Purity > 95%, by SDS-PAGE and RP-HPLC.